IMUTRAN

pharmaceutical preparations; preparations for use in transplantation, including genetically modified cells, tissues or organs; preparations for use in treating cancer, preparations for use in preventing or reducing complement activation or in activating complement; and synthetic DNA

surgical, medical, dental and veterinary apparatus and instruments; surgical implants, including genetically modified cells, tissues, and organs; dressings and suture material

live animals, including pigs

material treatment, including treatment of material to prevent or reduce the activation of complement

medical services, including transplantation surgery, cancer therapy and medical consultancy, medical clinics, diagnostic services, and research and development services